(WAT) Waters - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9418481035

WAT: Chromatography Systems, Mass Spectrometry Instruments, Thermal Analysis Instruments

Waters Corporation is a leading provider of analytical workflow solutions, operating across Asia, the Americas, and Europe through its two primary segments: Waters and TA. The company's product portfolio encompasses a range of high and ultra-performance liquid chromatography systems, as well as mass spectrometry technology systems and support products. This includes chromatography columns and other consumable products, which are essential for various laboratory applications. Additionally, the company offers post-warranty service plans, ensuring that its customers receive comprehensive support for their instruments.

The company's product line also features thermal analysis, rheometry, and calorimetry instruments, which are designed to predict the suitability and stability of various materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments are crucial for industries such as consumer goods, healthcare, and life science research. Furthermore, Waters Corporation develops and supplies software-based products that can interface with its own instruments, as well as those of other manufacturers. This enables customers to streamline their workflows and enhance their analytical capabilities.

Waters Corporation's mass spectrometry technology instruments play a vital role in drug discovery and development, including clinical trial testing and the analysis of proteins in disease processes. The company's products are also used for nutritional safety analysis and environmental testing, highlighting their versatility and importance in various fields. The company's customer base is diverse, comprising clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental organizations. These customers rely on Waters Corporation's products for research and development, quality assurance, and other laboratory applications.

With a history dating back to 1958, Waters Corporation has established itself as a prominent player in the life sciences tools and services industry. Headquartered in Milford, Massachusetts, the company continues to innovate and expand its product offerings, addressing the evolving needs of its customers. Its commitment to delivering high-quality analytical workflow solutions has earned it a reputation as a trusted partner in the scientific community. As a publicly traded company, Waters Corporation's common stock is listed on the New York Stock Exchange, providing investors with an opportunity to participate in its growth and success.

Additional Sources for WAT Stock

WAT Stock Overview

Market Cap in USD 22,584m
Sector Healthcare
Industry Diagnostics & Research
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception 1995-11-16

WAT Stock Ratings

Growth 5y 46.7%
Fundamental 67.6%
Dividend 0.30%
Rel. Strength Industry 811
Analysts 3.19/5
Fair Price Momentum 405.61 USD
Fair Price DCF 270.21 USD

WAT Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 1.0%

WAT Growth Ratios

Growth Correlation 3m 42.1%
Growth Correlation 12m 57%
Growth Correlation 5y 48.3%
CAGR 5y 11.74%
CAGR/Mean DD 5y 0.61
Sharpe Ratio 12m 0.82
Alpha 7.38
Beta 0.85
Volatility 27.53%
Current Volume 670.2k
Average Volume 20d 459.9k
What is the price of WAT stocks?
As of January 22, 2025, the stock is trading at USD 413.81 with a total of 670,200 shares traded.
Over the past week, the price has changed by +2.19%, over one month by +11.91%, over three months by +19.77% and over the past year by +30.52%.
Is Waters a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Waters (NYSE:WAT) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 67.57 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WAT as of January 2025 is 405.61. This means that WAT is currently overvalued and has a potential downside of -1.98%.
Is WAT a buy, sell or hold?
Waters has received a consensus analysts rating of 3.19. Therefor, it is recommend to hold WAT.
  • Strong Buy: 3
  • Buy: 0
  • Hold: 16
  • Sell: 2
  • Strong Sell: 0
What are the forecast for WAT stock price target?
According to ValueRays Forecast Model, WAT Waters will be worth about 446.9 in January 2026. The stock is currently trading at 413.81. This means that the stock has a potential upside of +8%.
Issuer Forecast Upside
Wallstreet Target Price 386.9 -6.5%
Analysts Target Price 383 -7.5%
ValueRay Target Price 446.9 8%